NewSquare Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-65
Closed -$628 892
2025
Q2
$628 Sell
65
-24
-27% -$248 ﹤0.01% 1111
2025
Q1
$1.32K Sell
89
-59
-40% -$907 ﹤0.01% 897
2024
Q4
$2.21K Buy
148
+61
+70% +$994 ﹤0.01% 531
2024
Q3
$1.66K Sell
87
-4
-4% -$83 ﹤0.01% 275
2024
Q2
$1.89K Sell
91
-52
-36% -$1.03K ﹤0.01% 289
2024
Q1
$2.68K Hold
143
﹤0.01% 334
2023
Q4
$2.06K Buy
143
+1
+0.7% +$14 ﹤0.01% 385
2023
Q3
$2.47K Buy
142
+1
+0.7% +$21 ﹤0.01% 443
2023
Q2
$2.94K Hold
141
﹤0.01% 486
2023
Q1
$3.31K Buy
141
+4
+3% +$107 ﹤0.01% 501
2022
Q4
$3.83K Sell
137
-15
-10% -$384 ﹤0.01% 402
2022
Q3
$4K Sell
152
-45
-23% -$1.36K ﹤0.01% 313
2022
Q2
$7K Hold
197
﹤0.01% 264
2022
Q1
$7K Sell
197
-198
-50% -$6.77K ﹤0.01% 283
2021
Q4
$12K Buy
395
+1
+0.3% +$33 ﹤0.01% 274
2021
Q3
$13K Buy
394
+10
+3% +$320 ﹤0.01% 257
2021
Q2
$12K Buy
+384
New +$12.6K ﹤0.01% 253

Other funds holding OGN

NewSquare Capital's OGN Position: Q3 2025 in Review

NewSquare Capital sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 65 shares — an estimated $628 sold.

NewSquare Capital first reported a position in OGN in Q2 2021 and held it in 17 quarters. The position peaked at $13K in Q3 2021. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • NewSquare Capital reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 65 Organon & Co shares in Q3 2025, an estimated $628.
  • NewSquare Capital first reported a position in Organon & Co in Q2 2021 and held it in 17 quarters.
  • NewSquare Capital's Organon & Co position peaked at $13K in Q3 2021.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.